10-Q Filing

Astrana Health, Inc. CIK: 1083446 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001628280-19-010579`
Period End Date	20190630
Filing Date	20190809
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	ameh-20190630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 102 Income Statement 84 Cash Flow Statement 115 Stockholders Equity 30

Balance Sheet 102 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$52.73M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$101.13M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.89M	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	-	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$3.54M	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$1.13M	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$1.15M	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$16.71M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$7.13M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	34.64M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	34.58M	shares	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$49.33M	USD	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$64.06M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$12.90M	USD	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	1.85M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$1.00M	USD	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	1.94M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$10.12M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$7.39M	USD	Point-in-time
Loan receivable related parties	`NotesReceivableRelatedPartiesCurrent`	-	USD	Point-in-time
Loan receivable related parties	`NotesReceivableRelatedPartiesCurrent`	$6.42M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$172.86M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$167.63M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.72M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.10M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$86.88M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$109.07M	USD	Point-in-time
Goodwill	`Goodwill`	$185.81M	USD	Point-in-time
Goodwill	`Goodwill`	$209.31M	USD	Point-in-time
Loans receivable related parties	`DueFromRelatedPartiesNoncurrent`	$17.50M	USD	Point-in-time
Loans receivable related parties	`DueFromRelatedPartiesNoncurrent`	$17.50M	USD	Point-in-time
Investment in other entities equity method	`EquityMethodInvestments`	$35.90M	USD	Point-in-time
Investment in other entities equity method	`EquityMethodInvestments`	$34.88M	USD	Point-in-time
Investment in a privately held entity that does not report net asset value per share	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$405.00K	USD	Point-in-time
Investment in a privately held entity that does not report net asset value per share	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$405.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$740.21K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$745.47K	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$14.32M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.35M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.21M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$340.14M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$400.70M	USD	Point-in-time
Total assets	`Assets`	$513.00M	USD	Point-in-time
Total assets	`Assets`	$568.33M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$30.66M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$25.08M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$1.54M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$1.80M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$63.97M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$42.94M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$33.64M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$11.62M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	-	USD	Point-in-time
Bank loan	`ShortTermBankLoansAndNotesPayable`	$40.26K	USD	Point-in-time
Bank loan	`ShortTermBankLoansAndNotesPayable`	-	USD	Point-in-time
Finance lease obligation	`FinanceLeaseLiabilityCurrent`	$101.74K	USD	Point-in-time
Finance lease obligation	`FinanceLeaseLiabilityCurrent`	$101.74K	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.84M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$78.34M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$72.02M	USD	Point-in-time
Lines of credit related party	`DueToRelatedPartiesNoncurrent`	$13.00M	USD	Point-in-time
Lines of credit related party	`DueToRelatedPartiesNoncurrent`	$44.60M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$19.62M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$26.65M	USD	Point-in-time
Liability for unissued equity shares	`LiabilityForUnissuedEquitySharesNoncurrent`	$1.19M	USD	Point-in-time
Liability for unissued equity shares	`LiabilityForUnissuedEquitySharesNoncurrent`	$1.19M	USD	Point-in-time
Finance lease obligation	`FinanceLeaseLiabilityNoncurrent`	$517.26K	USD	Point-in-time
Finance lease obligation	`FinanceLeaseLiabilityNoncurrent`	$466.77K	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$11.42M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$34.32M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$84.32M	USD	Point-in-time
Total liabilities	`Liabilities`	$106.34M	USD	Point-in-time
Total liabilities	`Liabilities`	$162.66M	USD	Point-in-time
Commitments and Contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation (APC)	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$219.58M	USD	Point-in-time
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation (APC)	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$225.12M	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 34,638,812 and 34,578,040 shares outstanding, excluding 1,944,054 and 1,850,603 treasury shares, at June 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$34.58K	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 34,638,812 and 34,578,040 shares outstanding, excluding 1,944,054 and 1,850,603 treasury shares, at June 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$34.64K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$163.89M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$162.72M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$17.79M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$21.47M	USD	Point-in-time
Stockholders' equity attributable to parent	`StockholdersEquity`	$185.40M	USD	Point-in-time
Stockholders' equity attributable to parent	`StockholdersEquity`	$180.55M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$689.93K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$998.32K	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$186.09M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$174.82M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$170.49M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$182.38M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders equity	`LiabilitiesAndStockholdersEquity`	$513.00M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders equity	`LiabilitiesAndStockholdersEquity`	$568.33M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$130.05M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$122.67M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$246.59M	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$225.81M	USD	2 Qtrs
Cost of services	`CostOfGoodsAndServicesSold`	$184.32M	USD	2 Qtrs
Cost of services	`CostOfGoodsAndServicesSold`	$184.80M	USD	2 Qtrs
Cost of services	`CostOfGoodsAndServicesSold`	$99.71M	USD	1 Quarter
Cost of services	`CostOfGoodsAndServicesSold`	$101.36M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$22.44M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$22.08M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$10.89M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$11.82M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$8.87M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.45M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.92M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$9.98M	USD	2 Qtrs
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	$2.31M	USD	1 Quarter
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	-	USD	1 Quarter
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	-	USD	2 Qtrs
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	$1.36M	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$115.52M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$214.39M	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$216.74M	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$115.32M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$7.15M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$14.73M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$11.42M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$29.85M	USD	2 Qtrs
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-42.28K	USD	1 Quarter
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.64M	USD	2 Qtrs
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.67M	USD	1 Quarter
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-891.94K	USD	2 Qtrs
Interest expense	`InterestExpense`	$110.68K	USD	1 Quarter
Interest expense	`InterestExpense`	$195.68K	USD	2 Qtrs
Interest expense	`InterestExpense`	$522.03K	USD	2 Qtrs
Interest expense	`InterestExpense`	$311.05K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$796.67K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$473.66K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$762.54K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$492.72K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$211.34K	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$275.75K	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$187.75K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$24.23K	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$2.48M	USD	2 Qtrs
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-405.95K	USD	2 Qtrs
Total other (expense) income, net	`NonoperatingIncomeExpense`	$144.56K	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$2.24M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$11.01M	USD	2 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$14.87M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$9.39M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$32.34M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$2.80M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$8.75M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$4.21M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.52M	USD	1 Quarter
Net income	`ProfitLoss`	$7.87M	USD	1 Quarter
Net income	`ProfitLoss`	$23.58M	USD	2 Qtrs
Net income	`ProfitLoss`	$8.21M	USD	2 Qtrs
Net income	`ProfitLoss`	$10.66M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.20M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.12M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.53M	USD	2 Qtrs
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$18.76M	USD	2 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$3.55M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$4.82M	USD	2 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$3.68M	USD	2 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$2.66M	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.11	USD	2 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.15	USD	2 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.08	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.10	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.07	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.09	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.13	USD	2 Qtrs
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.10	USD	2 Qtrs
Weighted average shares of common stock outstanding basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	34.52M	shares	2 Qtrs
Weighted average shares of common stock outstanding basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	32.67M	shares	1 Quarter
Weighted average shares of common stock outstanding basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	32.55M	shares	2 Qtrs
Weighted average shares of common stock outstanding basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	34.54M	shares	1 Quarter
Weighted average shares of common stock outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.94M	shares	2 Qtrs
Weighted average shares of common stock outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.96M	shares	1 Quarter
Weighted average shares of common stock outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.90M	shares	2 Qtrs
Weighted average shares of common stock outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.85M	shares	1 Quarter

Cash Flow Statement 115 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$7.87M	USD	1 Quarter
Net income	`ProfitLoss`	$23.58M	USD	2 Qtrs
Net income	`ProfitLoss`	$8.21M	USD	2 Qtrs
Net income	`ProfitLoss`	$10.66M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$8.87M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.45M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.92M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$9.98M	USD	2 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	2 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-41.78K	USD	2 Qtrs
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	$2.31M	USD	1 Quarter
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	-	USD	1 Quarter
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	-	USD	2 Qtrs
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	$1.36M	USD	2 Qtrs
Share-based compensation	`AllocatedShareBasedCompensationExpense`	$675.51K	USD	2 Qtrs
Share-based compensation	`AllocatedShareBasedCompensationExpense`	$1.04M	USD	2 Qtrs
Unrealized (gain) loss from investment in equity securities	`UnrealizedGainLossOnInvestments`	$14.55K	USD	2 Qtrs
Unrealized (gain) loss from investment in equity securities	`UnrealizedGainLossOnInvestments`	$-16.06K	USD	2 Qtrs
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-42.28K	USD	1 Quarter
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.64M	USD	2 Qtrs
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.67M	USD	1 Quarter
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-891.94K	USD	2 Qtrs
Deferred tax	`DeferredIncomeTaxExpenseBenefit`	$-549.20K	USD	2 Qtrs
Deferred tax	`DeferredIncomeTaxExpenseBenefit`	$706.81K	USD	2 Qtrs
Receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-4.41M	USD	2 Qtrs
Receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-587.64K	USD	2 Qtrs
Receivable, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$7.23M	USD	2 Qtrs
Receivable, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$12.67M	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$11.90M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$2.77M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$2.74M	USD	2 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$1.10M	USD	2 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	-	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$243.11K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$95.26K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$3.34M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-692.00K	USD	2 Qtrs
Dividends payable	`IncreaseDecreaseInDividendsPayable`	$617.21K	USD	2 Qtrs
Dividends payable	`IncreaseDecreaseInDividendsPayable`	-	USD	2 Qtrs
Incentives payable	`IncreaseDecreaseInIncentivesPayable`	-	USD	2 Qtrs
Incentives payable	`IncreaseDecreaseInIncentivesPayable`	$-16.40M	USD	2 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$260.21K	USD	2 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$-722.93K	USD	2 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$2.88M	USD	2 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-3.82M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-298.44K	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-11.62M	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOtherOperatingLeaseLiabilities`	$-1.04M	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOtherOperatingLeaseLiabilities`	-	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$13.42M	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-22.02M	USD	2 Qtrs
Payments for business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Payments for business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$41.52M	USD	2 Qtrs
Advances on loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	$2.50M	USD	2 Qtrs
Advances on loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	$6.42M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$3.93K	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$8.18K	USD	2 Qtrs
Purchases of investment - equity method	`PaymentsToAcquireEquityMethodInvestments`	$2.16M	USD	2 Qtrs
Purchases of investment - equity method	`PaymentsToAcquireEquityMethodInvestments`	$16.67M	USD	2 Qtrs
Purchases of a privately held entity that does not report net asset value per share	`PaymentOfInvestmentPrivatelyHeldEntityDoesNotReportToNAVPerShare`	-	USD	2 Qtrs
Purchases of a privately held entity that does not report net asset value per share	`PaymentOfInvestmentPrivatelyHeldEntityDoesNotReportToNAVPerShare`	$405.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$682.71K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$376.42K	USD	2 Qtrs
Dividend received	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$240.00K	USD	2 Qtrs
Dividend received	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-50.25M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-20.27M	USD	2 Qtrs
Repayment of bank loan	`RepaymentsOfRelatedPartyDebt`	$257.37K	USD	2 Qtrs
Repayment of bank loan	`RepaymentsOfRelatedPartyDebt`	$8.04M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$12.00M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$10.94M	USD	2 Qtrs
Change in noncontrolling interest capital	`ProceedsFromPaymentsToMinorityShareholders`	$27.50K	USD	2 Qtrs
Change in noncontrolling interest capital	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	2 Qtrs
Payment of capital lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$50.49K	USD	2 Qtrs
Payment of capital lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$49.00K	USD	2 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$2.35M	USD	2 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$898.10K	USD	2 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$40.00K	USD	2 Qtrs
Borrowings on line of credit	`ProceedsFromRelatedPartyDebt`	$39.60M	USD	2 Qtrs
Borrowings on line of credit	`ProceedsFromRelatedPartyDebt`	$8.00M	USD	2 Qtrs
Proceeds from common stock offering	`ProceedsFromIssuanceOfCommonStock`	$200.00K	USD	2 Qtrs
Proceeds from common stock offering	`ProceedsFromIssuanceOfCommonStock`	$205.00K	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.73M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$21.63M	USD	2 Qtrs
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-50.63M	USD	2 Qtrs
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-8.58M	USD	2 Qtrs
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$109.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$57.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$118.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$109.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$57.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$118.50M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$16.70M	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$11.61M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$144.54K	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$438.98K	USD	2 Qtrs
Cashless exercise of stock options	`CashlessExerciseOfStockOptions`	-	USD	2 Qtrs
Cashless exercise of stock options	`CashlessExerciseOfStockOptions`	$47.00	USD	2 Qtrs
Deferred tax liability adjustment to goodwill	`DeferredTaxLiabilityAdjustedToGoodwill`	$1.11M	USD	2 Qtrs
Deferred tax liability adjustment to goodwill	`DeferredTaxLiabilityAdjustedToGoodwill`	$8.36M	USD	2 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$52.73M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$101.13M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.89M	USD	Point-in-time
Restricted cash short-term - distributions to former NMM shareholders	`RestrictedCashEquivalentsCurrent`	$8.04M	USD	Point-in-time
Restricted cash short-term - distributions to former NMM shareholders	`RestrictedCashEquivalentsCurrent`	-	USD	Point-in-time
Restricted cash letters of credit	`RestrictedCashEquivalentsNoncurrent`	$4.28M	USD	Point-in-time
Restricted cash letters of credit	`RestrictedCashEquivalentsNoncurrent`	$745.35K	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$109.92M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$57.00M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$118.50M	USD	Point-in-time

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$186.09M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$174.82M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$170.49M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$182.38M	USD	Point-in-time
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$3.77M	USD	1 Quarter
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$2.75M	USD	1 Quarter
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$3.01M	USD	1 Quarter
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$549.89K	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	-	USD	1 Quarter
Purchase price adjustment from merger	`AdjustmentsToAdditionalPaidInCapitalMergerPurchasePriceAdjustment`	$868.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$423.55K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$1.92M	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$758.13K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$139.97K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$128.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$142.75K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	-	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$631.56K	USD	1 Quarter
Noncontrolling interest capital charge	`NoncontrollingInterestIncreaseFromCapitalCharge`	$27.50K	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$941.59K	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$186.09M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$174.82M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$170.49M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$182.38M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.